Literature DB >> 23647931

The pancreatic β cell and type 1 diabetes: innocent bystander or active participant?

Scott A Soleimanpour1, Doris A Stoffers.   

Abstract

Type 1 diabetes mellitus (T1DM) is a chronic disease resulting from destruction of insulin-producing pancreatic β cells. Genetic and environmental factors contribute to T1DM onset. Use of high-throughput DNA sequencing has allowed geneticists to perform genome-wide association studies (GWAS) to identify novel gene loci associated with T1DM. Interestingly, >50% of these genes encode products that are expressed in β cells. These studies, coupled with emerging molecular evidence that β cells are impaired by gain-of-function or loss-of-function of these loci, suggest an active role for the β cell in eliciting its own demise. Although immune dysregulation plays a vital role in T1DM pathogenesis, understanding the mechanisms contributing to β cell failure may lead to new strategies to preserve or improve β cell function in patients with T1DM.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23647931      PMCID: PMC3908840          DOI: 10.1016/j.tem.2013.03.005

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  98 in total

Review 1.  A comprehensive review of interventions in the NOD mouse and implications for translation.

Authors:  Lisl K M Shoda; Daniel L Young; Saroja Ramanujan; Chan C Whiting; Mark A Atkinson; Jeffrey A Bluestone; George S Eisenbarth; Diane Mathis; Aldo A Rossini; Scott E Campbell; Richard Kahn; Huub T C Kreuwel
Journal:  Immunity       Date:  2005-08       Impact factor: 31.745

2.  IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation.

Authors:  F Mercurio; H Zhu; B W Murray; A Shevchenko; B L Bennett; J Li; D B Young; M Barbosa; M Mann; A Manning; A Rao
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

3.  Huntingtin-interacting protein 14 is a type 1 diabetes candidate protein regulating insulin secretion and beta-cell apoptosis.

Authors:  Lukas Adrian Berchtold; Zenia Marian Størling; Fernanda Ortis; Kasper Lage; Claus Bang-Berthelsen; Regine Bergholdt; Jacob Hald; Caroline Anna Brorsson; Decio Laks Eizirik; Flemming Pociot; Søren Brunak; Joachim Størling
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-24       Impact factor: 11.205

4.  NF-kappa B prevents beta cell death and autoimmune diabetes in NOD mice.

Authors:  Sunshin Kim; Isabelle Millet; Hun Sik Kim; Ja Young Kim; Myoung Sook Han; Moon-Kyu Lee; Kwang-Won Kim; Robert S Sherwin; Michael Karin; Myung-Shik Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-31       Impact factor: 11.205

5.  Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism.

Authors:  Valérie Senée; Claude Chelala; Sabine Duchatelet; Daorong Feng; Hervé Blanc; Jack-Christophe Cossec; Céline Charon; Marc Nicolino; Pascal Boileau; Douglas R Cavener; Pierre Bougnères; Doris Taha; Cécile Julier
Journal:  Nat Genet       Date:  2006-05-21       Impact factor: 38.330

6.  BMP4-BMPR1A signaling in beta cells is required for and augments glucose-stimulated insulin secretion.

Authors:  Joan Goulley; Ulf Dahl; Nathalie Baeza; Yuji Mishina; Helena Edlund
Journal:  Cell Metab       Date:  2007-03       Impact factor: 27.287

7.  Exocrine pancreatic function in juvenile-onset diabetes mellitus.

Authors:  B M Frier; J H Saunders; K G Wormsley; I A Bouchier
Journal:  Gut       Date:  1976-09       Impact factor: 23.059

8.  Screening for insulitis in adult autoantibody-positive organ donors.

Authors:  Peter In't Veld; Dirk Lievens; Joeri De Grijse; Zhidong Ling; Bart Van der Auwera; Miriam Pipeleers-Marichal; Frans Gorus; Daniel Pipeleers
Journal:  Diabetes       Date:  2007-06-11       Impact factor: 9.461

9.  Progressive erosion of β-cell function precedes the onset of hyperglycemia in the NOD mouse model of type 1 diabetes.

Authors:  Diego Ize-Ludlow; Yaima L Lightfoot; Matthew Parker; Song Xue; Clive Wasserfall; Michael J Haller; Desmond Schatz; Dorothy J Becker; Mark A Atkinson; Clayton E Mathews
Journal:  Diabetes       Date:  2011-06-09       Impact factor: 9.461

10.  Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells.

Authors:  Elodie Roggli; Aurore Britan; Sonia Gattesco; Nathalie Lin-Marq; Amar Abderrahmani; Paolo Meda; Romano Regazzi
Journal:  Diabetes       Date:  2010-01-19       Impact factor: 9.461

View more
  29 in total

Review 1.  Transcriptional Regulation of the Pancreatic Islet: Implications for Islet Function.

Authors:  Michael L Stitzel; Ina Kycia; Romy Kursawe; Duygu Ucar
Journal:  Curr Diab Rep       Date:  2015-09       Impact factor: 4.810

2.  Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to Prevention.

Authors:  Emily K Sims; Susan Geyer; Suzanne Bennett Johnson; Ingrid Libman; Laura M Jacobsen; David Boulware; Lisa E Rafkin; Della Matheson; Mark A Atkinson; Henry Rodriguez; Maria Spall; Helena Elding Larsson; Diane K Wherrett; Carla J Greenbaum; Jeffrey Krischer; Linda A DiMeglio
Journal:  Diabetes Care       Date:  2019-09-26       Impact factor: 19.112

Review 3.  From discovery to function: the expanding roles of long noncoding RNAs in physiology and disease.

Authors:  Miao Sun; W Lee Kraus
Journal:  Endocr Rev       Date:  2014-11-26       Impact factor: 19.871

4.  Clarifying the function of genes at the chromosome 16p13 locus in type 1 diabetes: CLEC16A and DEXI.

Authors:  Morgan A Gingerich; Vaibhav Sidarala; Scott A Soleimanpour
Journal:  Genes Immun       Date:  2019-10-01       Impact factor: 2.676

Review 5.  Genomics of Islet (Dys)function and Type 2 Diabetes.

Authors:  Nathan Lawlor; Shubham Khetan; Duygu Ucar; Michael L Stitzel
Journal:  Trends Genet       Date:  2017-02-27       Impact factor: 11.639

Review 6.  Sodium-Glucose Cotransporter Inhibitors for the Treatment of Type 1 Diabetes Mellitus.

Authors:  Ning Li; Ruimin Chen; Kewei Liu
Journal:  Clin Drug Investig       Date:  2020-11       Impact factor: 2.859

Review 7.  Minireview: 12-Lipoxygenase and Islet β-Cell Dysfunction in Diabetes.

Authors:  Sarah A Tersey; Esther Bolanis; Theodore R Holman; David J Maloney; Jerry L Nadler; Raghavendra G Mirmira
Journal:  Mol Endocrinol       Date:  2015-03-24

8.  Selective inhibition of 12-lipoxygenase protects islets and beta cells from inflammatory cytokine-mediated beta cell dysfunction.

Authors:  David A Taylor-Fishwick; Jessica Weaver; Lindsey Glenn; Norine Kuhn; Ganesha Rai; Ajit Jadhav; Anton Simeonov; Angela Dudda; Dieter Schmoll; Theodore R Holman; David J Maloney; Jerry L Nadler
Journal:  Diabetologia       Date:  2014-11-23       Impact factor: 10.122

Review 9.  Nucleic acid biomarkers of β cell stress and death in type 1 diabetes.

Authors:  Farooq Syed; Carmella Evans-Molina
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-08       Impact factor: 3.243

10.  The diabetes susceptibility gene Clec16a regulates mitophagy.

Authors:  Scott A Soleimanpour; Aditi Gupta; Marina Bakay; Alana M Ferrari; David N Groff; João Fadista; Lynn A Spruce; Jake A Kushner; Leif Groop; Steven H Seeholzer; Brett A Kaufman; Hakon Hakonarson; Doris A Stoffers
Journal:  Cell       Date:  2014-06-19       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.